Patents Assigned to CENTRE JEAN PERRIN
  • Publication number: 20140142168
    Abstract: The present invention relates to a combination of a curcuminoid and a taxane for use in the treatment of a hormone-refractory prostate cancer (HRPC) in a patient in need thereof.
    Type: Application
    Filed: April 27, 2012
    Publication date: May 22, 2014
    Applicants: CENTRE JEAN PERRIN, Institut National de la Sante et de la Recherche Medicale (INSERM), UNIVERSITE D'AUVERGNE CLERMONT
    Inventors: Chantal Barthomeuf, Philippe Chollet, Eloise Planchat, Hervé Cure